Translational Development Acquisition Corp. (TDAC) reporting calendar
Translational Development Acquisition Corp. files periodic reports with the SEC as TDAC on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 23 Jul 2026 – 5 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 15 May 2026
- Reports on record
- 6
How this window is derived. Derived from this issuer's own filing history: 6 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open TDAC market profile
Latest filing on SEC EDGAR ↗
Blank Checks reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 15 May 2026 | 45 days | 0001104659-26-061556 |
| 10-K | 31 Dec 2025 | 30 Mar 2026 | 89 days | 0001104659-26-036811 |
| 10-Q | 30 Sep 2025 | 14 Nov 2025 | 45 days | 0001104659-25-112494 |
| 10-Q | 30 Jun 2025 | 14 Aug 2025 | 45 days | 0001410578-25-001812 |
| 10-Q | 31 Mar 2025 | 15 May 2025 | 45 days | 0001410578-25-001344 |
| 10-K | 31 Dec 2024 | 31 Mar 2025 | 90 days | 0001410578-25-000576 |
Source: SEC EDGAR company submissions for CIK 0001926599. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.